554 related articles for article (PubMed ID: 17018037)
41. Adaptive immunity in the colostrum-deprived calf: response to early vaccination with Mycobacterium bovis strain bacille Calmette Guerin and ovalbumin.
Nonnecke BJ; Waters WR; Goff JP; Foote MR
J Dairy Sci; 2012 Jan; 95(1):221-39. PubMed ID: 22192201
[TBL] [Abstract][Full Text] [Related]
42. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
Kawahara M; Matsuo K; Honda M
Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
[TBL] [Abstract][Full Text] [Related]
43. Intraduodenal vaccination of brushtail possums with bacille Calmette-Guérin enhances immune responses and protection against Mycobacterium bovis infection.
Buddle BM; Aldwell FE; Keen DL; Parlane NA; Yates G; de Lisle GW
Int J Tuberc Lung Dis; 1997 Aug; 1(4):377-83. PubMed ID: 9432396
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical markers augment evaluation of vaccine efficacy and disease severity in bacillus Calmette-Guerin (BCG) vaccinated cattle challenged with Mycobacterium bovis.
Johnson L; Gough J; Spencer Y; Hewinson G; Vordermeier M; Wangoo A
Vet Immunol Immunopathol; 2006 Jun; 111(3-4):219-29. PubMed ID: 16540176
[TBL] [Abstract][Full Text] [Related]
45. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
Waeckerle-Men Y; Bruffaerts N; Liang Y; Jurion F; Sander P; Kündig TM; Huygen K; Johansen P
Vaccine; 2013 Feb; 31(7):1057-64. PubMed ID: 23273509
[TBL] [Abstract][Full Text] [Related]
46. The cytokine response to bacille Calmette Guérin vaccination in South India.
Das SD; Narayanan PR; Kolappan C; Colston MJ
Int J Tuberc Lung Dis; 1998 Oct; 2(10):836-43. PubMed ID: 9783532
[TBL] [Abstract][Full Text] [Related]
47. Requirements for CD4(+) T cell levels in acute Mycobacterium bovis strain bacille Calmette Guerin (BCG)-induced granulomas differ for optimal mycobacterial control versus granuloma formation.
Hogan LH; Heninger E; Elsner RA; Vonderheid HA; Hulseberg P; Co D; Sandor M
Int Immunol; 2007 May; 19(5):627-33. PubMed ID: 17446212
[TBL] [Abstract][Full Text] [Related]
48. Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis.
Buddle BM; Aldwell FE; Skinner MA; de Lisle GW; Denis M; Vordermeier HM; Hewinson RG; Wedlock DN
Vaccine; 2005 May; 23(27):3581-9. PubMed ID: 15855017
[TBL] [Abstract][Full Text] [Related]
49. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
[TBL] [Abstract][Full Text] [Related]
50. Mycobacterium bovis bacillus Calmette-Guérin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production.
Martino A; Badell E; Abadie V; Balloy V; Chignard M; Mistou MY; Combadière B; Combadière C; Winter N
J Immunol; 2010 Feb; 184(4):2038-47. PubMed ID: 20083674
[TBL] [Abstract][Full Text] [Related]
51. Failure of a Mycobacterium tuberculosis DeltaRD1 DeltapanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elicited by M. bovis bacille Calmette Guerin.
Waters WR; Palmer MV; Nonnecke BJ; Thacker TC; Scherer CF; Estes DM; Jacobs WR; Glatman-Freedman A; Larsen MH
Vaccine; 2007 Nov; 25(45):7832-40. PubMed ID: 17931755
[TBL] [Abstract][Full Text] [Related]
52. Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A.
Gartner T; Baeten M; Otieno S; Revets H; De Baetselier P; Huygen K
Immunol Lett; 2007 Jul; 111(1):26-35. PubMed ID: 17570535
[TBL] [Abstract][Full Text] [Related]
53. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
[TBL] [Abstract][Full Text] [Related]
54. Targeted induction of antigen expression within dendritic cells modulates antigen-specific immunity afforded by recombinant BCG.
Kong CU; Ng LG; Nambiar JK; Spratt JM; Weninger W; Triccas JA
Vaccine; 2011 Feb; 29(7):1374-81. PubMed ID: 21211591
[TBL] [Abstract][Full Text] [Related]
55. Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations.
Whelan AO; Wright DC; Chambers MA; Singh M; Hewinson RG; Vordermeier HM
Vaccine; 2008 Jan; 26(2):166-73. PubMed ID: 18055073
[TBL] [Abstract][Full Text] [Related]
56. [Immunogenicity of interleukin 12 and DNA vaccine prime-BCG boost against Mycobacterium tuberculosis].
Gao L; Bao L; Hao M; Zhang L; Qin ZF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):535-9. PubMed ID: 18798487
[TBL] [Abstract][Full Text] [Related]
57. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
[TBL] [Abstract][Full Text] [Related]
58. Flow cytometric detection of gamma interferon can effectively discriminate Mycobacterium bovis BCG-vaccinated cattle from M. bovis-infected cattle.
Sopp P; Howard CJ; Hope JC
Clin Vaccine Immunol; 2006 Dec; 13(12):1343-8. PubMed ID: 17005929
[TBL] [Abstract][Full Text] [Related]
59. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
Giri PK; Verma I; Khuller GK
J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
[TBL] [Abstract][Full Text] [Related]
60. In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guérin.
Worku S; Hoft DF
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S257-61. PubMed ID: 10875795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
